BPC-157 + TB-500 Pre-Filled Pen

30mg total · 2 compounds: 15mg BPC-157 + 15mg TB-500 · pre-filled pen kit

2 photos · Enlarge

Price · per pen

£120.00

Made to order

£4.95 UK delivery · free £50+ Royal Mail Tracked 24

Dispatch follows order review.

Batch documentation

View Certificate of Analysis ↗

BPC-157/TB-500 10mg component-vial COA - three vials per prepared product

Explore research & studies

Product overview & specifications

BPC-157 + TB-500 Pre-Filled Pen in pre-filled pen. Check the product record for the stated strength, storage information and batch-document availability.

Strength: 30mg pre-filled pen
Presentation: Pre-filled pen
Batch documentation: availability shown on this listing

Strength30mg pre-filled pen

PresentationPre-filled pen

Purity99%+

Storage2-8 C

Part number: CP-ACC-007
Storage: Store refrigerated at 2-8 C, protected from light.
COA: View BPC-157/TB-500 10mg component-vial COA - three vials per prepared product; included securely in your account after ordering
Delivery: Royal Mail Tracked 24 is £4.95, or free on merchandise subtotals of £50+
Tracking: Emailed once dispatched and shown in your profile
Contents: 1 pre-filled pen presentation
Status: Research use only
Preparation: Made to order from batch-tracked components. Prepared presentations are not held pre-filled: preparation takes place after ordering to minimise time in the prepared state before dispatch. Refrigerate at 2-8 C and protect from light on receipt. Stability depends on the compound, preparation and storage conditions; retain the supplied batch documentation.

For laboratory research only

For laboratory research use only. Not for human or veterinary use. No use instructions or medical guidance is provided. Understand COA documentation.

Research information

BPC-157 + TB-500 Pre-Filled Pen research profile

What is being studied?

Wolverine is a documented combination of BPC-157 and TB-500 research components rather than a single molecular entity. The combined format is intended for controlled blend-versus-component comparison.

Published component studies include BPC-157 experiments involving fibroblast migration and FAK-paxillin signalling, plus thymosin-beta-derived peptide studies involving actin binding and cell migration. These component findings do not establish a unified mechanism for the blend.

Research areas

Blend-versus-component analytical and cell-based comparisons
Fibroblast migration and FAK-paxillin pathway assays
Actin-binding, cytoskeletal and cell-motility research models

Selected studies

Cell and tissue study · 2011
BPC-157, fibroblast migration and FAK-paxillin ↗
Investigated BPC-157 in rat tendon explants and cultured fibroblasts; it did not test a combined blend.
Related peptide study · 2003
Thymosin beta-4 actin-binding-site research ↗
Studied thymosin beta-4 and its actin-binding fragments in cell and tissue models. This does not verify the supplied TB-500 material or blend.

How to read this research

These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.

Technical product record

BPC-157 + TB-500 Pre-Filled Pen research record

Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this pre-filled pen.

Molecular identity

Two-component peptide research blend

Sequence / composition

15mg BPC-157 + 15mg TB-500

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.